Shanghai Kinetic Medical Co., Ltd. (SZSE:300326) signed an equity transfer agreement to acquire remaining 43.05% stake in Essen Technology (Beijing) Co., Ltd. from Shanghai Yi'an Investment Center (Limited Partnership), Shanghai Chunhe Investment Management (Limited Partnership), Lin Wei and Qiao Yinling for approximately CNY 320 million in stock on January 22, 2016. As consideration, Shanghai Kinetic Medical Co., Ltd. will issue 17.06 million shares at CNY 18.96 per share. After the transaction, Shanghai Kinetic Medical Co., Ltd will hold 100% stake in Essen Technology (Beijing) Co., Ltd. Essen Technology (Beijing) had total assets of CNY 193.94 million and total owners' equity of CNY 165.57 million as of August 2015.

The transaction is still subject to approval by the shareholders of Shanghai Kinetic Medical and CSRC. The shareholders of Essen Technology and Board of Directors of Shanghai Kinetic Medical approved the transaction. The shareholders' of Shanghai Kinetic Medical Co., Ltd approved the transaction.

China Securities Regulatory Commission approved the transaction. Sinolink Securities Co., Ltd. acted as financial advisor, King & Wood Mallesons acted as legal advisors and Moore Stephens Da Hua acted as an accountant for Shanghai Kinetic Medical.